Government to notify cardiac stent pricing in 15 days

Prices of both metallic and drug-eluting likely to be brought down once notification is announced

Image via Shutterstock
<a href="http://www.shutterstock.com/pic-324804920.html" target="_blank">Image</a> via Shutterstock
Ayan Pramanik Bengaluru
Last Updated : Jan 28 2017 | 5:42 PM IST
Union Pharmaceutical Minister Ananth Kumar on Saturday said the centre would issue a notification to control the prices of cardiac stents, an artificial tube inserted in the human heart for proper blood circulation.

Prices of both metallic stents and drug-eluting stents, ones which put drug inside the coronary arteries, are expected to be brought down once the Department of Pharmaceuticals announces the notification “within next 15 days”.

“Since cardiac are schedule 1 medicine under National List of Essential Medicine, under Drug Price Control Order we have issued a notification of price fixation for stents. Within next 15 days the notification will come before the country and all the cardiac stents prices will be reduced in a great way and they will be controlled,” said Kumar at an event to announce an international conference on medical device sector in Bengaluru.

He pointed out that people are often “exploited by private hospitals” on the prices of stents. While the manufacturing cost for stents is around 10,000, people end up paying between 1 to 1.5 lakh for a stent.

The Department of Pharmaceuticals had proposed the inclusion of stents within NLEM middle of last year and it was based on recommendations made by a sub-committee of expert cardiologists.

While the use of cardiac stents has reportedly gone up by three times during the past five years, India currently imports one out of every two stents used.

Kumar also said prices of 1,150 life-saving medicines under NLEM have been reduced between 60% and 93%. “We have also come out with an app called Pharma Sahi Dam to help people know the right price/controlled price of a particular medicine. And one can raise complaints using another app called Pharma Jan Samadhan if any hospital or pharmacy do not accept the controlled price.”

Meanwhile, he said that State governments of Andhra Pradesh, Telangana, Maharashtra, Gujarat, Karnataka, Himachal Pradesh have shown interest and are in talks to open pharma and medical device parks. “The Andhra Pradesh government proposed to give 300 acres land at throw-away prices. The Government of India along with industries will put around Rs 200 crore initially for the part in Andhra Pradesh.” 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story